title: Pentoxifylline therapy in dermatology. A review of localized hyperviscosity and its effects on the skin.
abstract: The conditions treatable with PTX are limited only by our understanding of disease pathogenesis. Surely the reader will think of new applications. I would caution at this point that PTX is not the primary treatment for any cutaneous condition but may be a valuable therapeutic adjunct.
authors.affiliation: Department of Dermatology, University of California, Davis.
authors.forename: H
authors.initials: H
authors.lastname: Ely
mesh_terms: D001773:Blood Cells / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects*; D004347:Drug Interactions; D006801:Humans; D010431:Pentoxifylline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology; D012871:Skin Diseases / Q000097:blood / Q000188:drug therapy*; D013805:Theobromine / Q000031:analogs & derivatives*
chemical_list: D013805:Theobromine; D010431:Pentoxifylline